Login / Signup

Correlation of limited-early-response status with 12-month CST, BVA, and machine learning-quantified retinal fluid in diabetic macular oedema in routine clinical practice.

Resya C SastryScott W PerkinsAneesha KalurRishi P Singh
Published in: Eye (London, England) (2024)
BVA and CST M12 outcomes vary by aLER/aER status indicating that CST may be a strong predictor of treatment outcomes, while retinal fluid volumes were not predicted by LER status.
Keyphrases
  • optical coherence tomography
  • clinical practice
  • diabetic retinopathy
  • machine learning
  • type diabetes
  • artificial intelligence
  • metabolic syndrome
  • skeletal muscle
  • glycemic control